BSGM BioSig Technologies, Inc. Stock Quote

BSGM [NASD]

Index	-	P/E	-	EPS (ttm)	-1.04	Insider Own	5.30%	Shs Outstand	34.86M	Perf Week	-14.61%
Market Cap	99.60M	Forward P/E	-	EPS next Y	-0.76	Insider Trans	1.50%	Shs Float	30.67M	Perf Month	-15.43%
Income	-33.60M	PEG	-	EPS next Q	-0.23	Inst Own	13.60%	Short Float	6.73%	Perf Quarter	-14.61%
Sales	0.40M	P/S	249.00	EPS this Y	-13.70%	Inst Trans	-2.99%	Short Ratio	9.22	Perf Half Y	-31.69%
Book/sh	0.52	P/B	5.06	EPS next Y	20.60%	ROA	-142.00%	Target Price	13.00	Perf Year	-43.32%
Cash/sh	0.46	P/C	5.69	EPS next 5Y	-	ROE	-175.50%	52W Range	2.26 - 6.14	Perf YTD	-32.56%
Dividend	-	P/FCF	-	EPS past 5Y	-1.50%	ROI	-	52W High	-57.17%	Beta	1.60
Dividend %	-	Quick Ratio	7.00	Sales past 5Y	-	Gross Margin	54.00%	52W Low	16.37%	ATR	0.27
Employees	49	Current Ratio	7.80	Sales Q/Q	-	Oper. Margin	-	RSI (14)	41.32	Volatility	9.47% 8.58%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	45.70%	Profit Margin	-	Rel Volume	0.90	Prev Close	2.82
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	223.95K	Price	2.63
Recom	2.00	SMA20	-17.73%	SMA50	-8.84%	SMA200	-24.95%	Volume	201,789	Change	-6.74%

Mar-30-20

Initiated

ROTH Capital

Buy

Dec-01-21 09:25AM	BioSig Technologies, Inc. Appoints Gray Fleming as Chief Commercial Officer GlobeNewswire
Nov-17-21 09:45AM	BioSig to Participate in the The Benchmark Company 10th Annual Discovery Conference GlobeNewswire +6.22%
Nov-16-21 09:52AM	BioSig Initiates Artificial Intelligence Development Program with Technion Israel Institute of Technology GlobeNewswire +13.50%
Nov-11-21 02:45PM	BioSig to Host Live Roundtable Webinar to Discuss Clinical Data Delivered With Its Signal Processing Technology For Arrhythmia Care GlobeNewswire
Nov-10-21 09:20AM	BioSig Adds To Its Clinical Footprint In Texas GlobeNewswire
Nov-08-21 11:30AM	BioSig Installs its Signal Processing Technology for Arrhythmia Care at a Leading Hospital in Boston GlobeNewswire
Nov-04-21 11:00AM	BioSig Expands its Installation Base in Texas GlobeNewswire
Nov-01-21 12:30PM	BioSig Increases Case Volume Estimates GlobeNewswire +20.37%
Oct-13-21 09:01AM	Clinical Data Published in the Journal of Cardiovascular Electrophysiology Could Be Important for This Stock Benzinga
Oct-12-21 09:15AM	BioSigs PURE EP System to be Featured in a Live Patient Case During Annual International Symposium on Ventricular Arrhythmias GlobeNewswire
Oct-07-21 12:41PM	BioSig Inks Manufacturing Deal with Plexus Corp Benzinga
Oct-04-21 08:30AM	Clinical Data Acquired by the PURE EP System Published in the Journal of Cardiac Electrophysiology GlobeNewswire -6.71%
Sep-28-21 09:15AM	BioSig Selects Plexus Corp. as its Manufacturing Partner GlobeNewswire -6.89%
Sep-23-21 09:47AM	BioSig's PURE EP Aims to Address Unmet Needs of Afib Patients Benzinga
06:43AM	Can BioSig Technologies (NASDAQ:BSGM) Afford To Invest In Growth? Simply Wall St.
Sep-21-21 10:30AM	BioSig Technologies, Inc. Appoints Medical Device Industry Leader to its Board of Directors GlobeNewswire
Sep-17-21 07:40AM	BioSig Expands in Electrophysiology with St. Elizabeth's Medical Center Evaluation Benzinga
Sep-13-21 08:00AM	BioSig Increases Installation Footprint Adding St. Elizabeths Medical Center to Roster of Premium Medical Institutions Utilizing the PURE EP System GlobeNewswire
Sep-02-21 09:41AM	4 Penny Stocks Insiders Are Buying Benzinga
Aug-31-21 10:00AM	BioSig Confirmed as a Participant of The Mark E. Josephson Twenty-Eight Annual State-of-the-Art Arrhythmia Virtual Symposium GlobeNewswire
Aug-19-21 11:00AM	BioSigs Signal Processing System for Arrhythmia Care To Be Featured At The Kansas City Heart Rhythm Symposium GlobeNewswire -8.14%
Jul-20-21 02:00PM	BioSig To Host Presentations from Physician Users of its Signal Processing System for Arrhythmia Care during the annual Heart Rhythm 2021 convention GlobeNewswire
Jul-13-21 02:30PM	BioSig Latest Installation Broadens Clinical Footprint for its Signal Processing Technology for Electrophysiology GlobeNewswire
Jul-12-21 10:30AM	BioSig to Host Conference Call to Unblind Clinical Data Collected with its Signal Processing Technology for Arrhythmia Care GlobeNewswire
Jul-07-21 04:10PM	BioSig Announces Closing of Public Offering of Common Stock GlobeNewswire -7.11%
09:36AM	BioSig Enters the New York Market with Its Signal Processing Technology for Electrophysiology GlobeNewswire
Jul-06-21 09:44AM	Mayo Clinic Purchases BioSig's PURE EP for use at its Phoenix Location Benzinga -5.52%
Jul-02-21 09:37AM	BioSig Technologies Raises $10M Via Equity Issued At $4/Share Benzinga
08:15AM	BioSig Announces Pricing of Public Offering of Common Stock GlobeNewswire
Jul-01-21 04:05PM	BioSig Announces Proposed Public Offering of Common Stock GlobeNewswire +12.69%
Jun-30-21 10:03AM	BioSig Completes 1000 Patient Cases with its Signal Processing System for Electrophysiology Benzinga -6.31%
09:35AM	BioSig Completes 1000 Patient Cases with its Signal Processing System for Electrophysiology GlobeNewswire
Jun-28-21 09:45AM	BioSigs Signal Processing Technology for Electrophysiology To Be Featured During 2021 Stanford Biodesign New Arrhythmia Technologies Retreat GlobeNewswire +15.56%
Jun-22-21 10:06AM	BioSigs Signal Processing System for Electrophysiology Featured in Two Clinical and Scientific Presentations during the annual Heart Rhythm 2021 convention GlobeNewswire
Jun-15-21 02:14PM	Where Do Hedge Funds Stand On BioSig Technologies, Inc. (BSGM)? Insider Monkey
08:30AM	BioSig Technologies, Inc. to Present New Clinical Data at Heart Rhythm 2021 Annual Convention GlobeNewswire
Jun-07-21 08:30AM	BioSig Technologies, Inc. to Present at the LD Micro Invitational XI Virtual Event GlobeNewswire +8.45%
May-28-21 10:30AM	BioSig Technologies, Inc. to Present at the Jefferies Virtual Healthcare Conference GlobeNewswire
May-24-21 09:44AM	The Power and Precision of BioSig's PURE EP System in the Electrophysiology (EP) Market Benzinga
May-21-21 09:15AM	BioSig Technologies, Inc. to Present at the Oppenheimer MedTech, Tools & Diagnostics Summit GlobeNewswire
May-04-21 06:28PM	BioSig Sees Increased Case Volume from Expanding Base of Medical Centers Using Its Proprietary Signal Processing System Benzinga
09:15AM	BioSig Sees Increased Case Volume from Expanding Base of Medical Centers Using Its Proprietary Signal Processing System GlobeNewswire
May-03-21 12:00PM	BioSig Technologies, Inc. Invited to Present at Wall Street Conference GlobeNewswire
01:56AM	Is BioSig Technologies, Inc.'s (NASDAQ:BSGM) Shareholder Ownership Skewed Towards Insiders? Simply Wall St.
Apr-27-21 09:30AM	BioSigs PURE EP(tm) System Evaluated with Patients at Mayo Clinic in Arizona GlobeNewswire
Apr-15-21 11:45AM	BioSig Expands Commercial Team in Two Strategic Regions GlobeNewswire
Apr-14-21 09:29AM	BioSig Launches Enhanced Signal Processing Capabilities for Advanced Cardiac Signal Analysis Through its Electrophysiology Platform GlobeNewswire
Apr-13-21 09:32AM	BioSig Completes Enrollment in the PURE EP 2.0 Clinical Study GlobeNewswire
Apr-09-21 09:32AM	BioSig Invited to Join Alliance for Artificial Intelligence in Healthcare (AAIH) GlobeNewswire
Apr-08-21 09:32AM	EP Lab Digest Features Physician Experience with BioSigs Cardiac Signal Acquisition Technology GlobeNewswire +6.41%
Apr-06-21 09:45AM	BioSig lands Commercial Sales to Leading Hospital System GlobeNewswire
Apr-05-21 10:00AM	BioSig Technologies, Inc. to Present at the 20th Annual Needham Virtual Healthcare Conference GlobeNewswire +6.03%
Mar-30-21 08:30AM	BioSig Awarded U.S. Patent Claims for the Noise-Filtering Methods for its Signal Processing Technology GlobeNewswire +5.58%
Mar-29-21 09:15AM	BioSig Issues Shareholder Letter with Corporate Update on Recent Achievements and Anticipated Milestones for 2021 GlobeNewswire
Mar-19-21 12:15PM	BioSig CEO Kenneth L. Londoner to Present at the Benzinga Biotech Small Cap Conference GlobeNewswire
Mar-10-21 05:30PM	BioSig CEO Kenneth L. Londoner to Present at the Oppenheimer 31st Annual Healthcare Conference GlobeNewswire
Mar-09-21 04:45PM	BioSig CEO Kenneth L. Londoner to Present at the 33rd Annual Virtual ROTH Conference GlobeNewswire +9.16%
Mar-05-21 09:44AM	The Future of Medicine is Here: Bioelectronic Medicine Benzinga
Mar-04-21 09:15AM	BioSig Awarded U.S. Patent Claims for its NeuroClear Subsidiary GlobeNewswire
Feb-16-21 08:45AM	BioSig Appoints Brenda Castrodad to Lead Human Resources GlobeNewswire -5.25%
Feb-11-21 08:30AM	Global Cardiovascular Devices Market Now Project to Exceed $71 Billion By 2027 PR Newswire +5.34%
Feb-10-21 10:00AM	Major Medical Centers Enter into Installation Agreements for Evaluation of BioSig PURE EP Systems GlobeNewswire
Feb-08-21 08:35AM	Small and Microcap Company Investor Presentations Now Available for On-Demand Viewing PR Newswire
Feb-02-21 08:00AM	BioSig and Mayo Clinic Collaborate on New R&D Program to Develop Transformative AI and Machine Learning Technologies for its PURE EP System GlobeNewswire
Jan-28-21 08:35AM	Live Investor Conference & Webinar: Small and Microcap Company Showcase on February 4th PR Newswire
Jan-27-21 04:30PM	BioSig CEO Kenneth L. Londoner to Present at the Virtual Investor Conference Small and Microcap Showcase GlobeNewswire
Jan-15-21 09:32AM	BioSig to Present at the 26th Annual International AF Symposium GlobeNewswire -8.71%
Jan-14-21 09:32AM	BioSig PURE EP System Featured in the Editorial of EP Lab Digest GlobeNewswire
Jan-13-21 01:35PM	Why Vuzix Stock Popped Today Motley Fool +8.01%
09:32AM	BioSig Deploys Vuzix M400 Smart Glasses to Offer Remote Servicing Capabilities in Compliance with COVID-19 Travel Restrictions GlobeNewswire
07:00AM	Sidoti Virtual Investor Conference ACCESSWIRE
Jan-12-21 09:32AM	BioSig Conducts First Patient Cases with PURE EP(tm) System at Memorial Hospital of South Bend, Indiana GlobeNewswire +13.53%
Jan-11-21 12:13AM	Are Insiders Buying BioSig Technologies, Inc. (NASDAQ:BSGM) Stock? Simply Wall St.
Jan-06-21 10:00AM	BioSig CEO Kenneth L. Londoner to Present at the Sidoti Winter 2021 Investor Conference GlobeNewswire +7.67%
Dec-18-20 08:30AM	BioSigs Division NeuroClear Technologies Signs a Research Agreement with the University of Minnesota GlobeNewswire
Dec-16-20 09:45AM	BioSig Technologies Achieves First Commercial Sale Of Its PURE EP System Benzinga -5.27%
Dec-11-20 07:51AM	BioSig Announces First Sale Of Cardiac Signal Processing Systems Benzinga +8.83%
07:30AM	BioSig Achieves First Commercial Sale of Three PURE EP Systems GlobeNewswire
Dec-10-20 03:00PM	BioSig CEO Kenneth L. Londoner to Present at the 13th Annual LD Micro Main Event Conference GlobeNewswire +6.56%
Dec-03-20 11:00AM	BioSig to Highlight PURE EP System at the Benzinga Global Small Cap Conference GlobeNewswire
Dec-02-20 11:41AM	Insider Buys BioSig Technologies Stock Benzinga
Nov-30-20 11:00AM	BioSigs PURE EP System to Support Live Patient Cases during EPLive 2020 GlobeNewswire
Nov-19-20 11:32AM	Insider Buys BioSig Technologies Shares Benzinga +5.03%
Nov-12-20 02:11PM	BioSig to Host Business Update Conference Call on November 18, 2020 GlobeNewswire
05:56AM	Is BioSig Technologies (NASDAQ:BSGM) In A Good Position To Invest In Growth? Simply Wall St.
Oct-29-20 02:05PM	BioSig Announces Completion of PURE EP System Installation at New Medical Center GlobeNewswire
Oct-28-20 10:00AM	BioSig Issues October 2020 Shareholder Update Letter GlobeNewswire +12.54%
Oct-26-20 11:04AM	Biosig stock plunges to lead Nasdaq losers after trial of COVID-19 treatment halted MarketWatch -39.64%
07:30AM	ViralClear halts its Phase 2 Hospitalized COVID-19 Trial GlobeNewswire
Sep-30-20 09:27AM	SORRENTO THERAPEUTICS AND VIRALCLEAR ENTER INTO AGREEMENT TO EXPLORE THE COMBINATION OF ANTIBODY AND ANTIVIRAL ASSETS AGAINST COVID-19 GlobeNewswire
Sep-22-20 10:55AM	ViralClear Expands Ongoing Phase 2 Trial Size for its Oral Anti-Viral for the Treatment of COVID-19, Expands Trial Locations and Appoints Contract Manufacturing Organization to Manufacture Phase 3 Supplies of Merimepodib Oral Solution GlobeNewswire -33.66%
Sep-21-20 11:01AM	Reminder: ViralClear to Host Conference Call and Webcast on September 22, 2020 to Discuss Phase 2 Human Trial of AntiViral Merimepodib Oral Solution for Treatment of COVID-19 GlobeNewswire -5.35%
Sep-15-20 10:00AM	BioSig Releases PURE EP Study Abstract with Data Presented at European Society of Cardiologys ESC Congress 2020 GlobeNewswire +7.29%
Sep-14-20 03:00PM	BioSig Announces Abstract Acceptance to Computing in Cardiology 2020 GlobeNewswire
10:29AM	Reminder: BioSig to Host Conference Call and Webcast on September 15, 2020 to Discuss Unblinding of PURE EP Human Data GlobeNewswire
Sep-09-20 12:15PM	ViralClear to Host Conference Call on September 22, 2020, to Discuss Phase 2 Human Trial of AntiViral Merimepodib Oral Solution for Treatment of COVID-19 GlobeNewswire -9.67%
Sep-02-20 10:15AM	BioSig to Host Conference Call on September 15, 2020 to Discuss Unblinding of PURE EP Human Data GlobeNewswire +8.78%
Aug-31-20 05:00PM	LD Micro 360 Companies Set to Present this Week ACCESSWIRE
Aug-25-20 10:45AM	BioSig Technologies to Present at The LD 500 Virtual Conference ACCESSWIRE
08:30AM	BioSig Technologies to Present at The LD 500 Virtual Conference GlobeNewswire

BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation and ventricular tachycardia. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
LONDONER KENNETH L	Chief Executive Officer	Sep 21	Buy	2.85	5,950	16,958	1,719,244	Sep 29 01:56 PM
LONDONER KENNETH L	Chief Executive Officer	Sep 20	Buy	2.81	2,636	7,407	1,713,294	Sep 29 01:56 PM
LONDONER KENNETH L	Chief Executive Officer	Sep 02	Buy	3.09	1,200	3,713	1,710,658	Sep 02 12:56 PM
LONDONER KENNETH L	Chief Executive Officer	Sep 01	Buy	3.10	4,400	13,624	1,709,458	Sep 02 12:56 PM
LONDONER KENNETH L	Chief Executive Officer	Sep 01	Buy	3.09	6,400	19,802	1,705,058	Sep 01 12:48 PM
LONDONER KENNETH L	Chief Executive Officer	Aug 30	Buy	3.02	9,000	27,194	1,698,658	Aug 31 10:00 AM
CHAUSSY STEVE	Chief Financial Officer	May 21	Buy	3.38	2,000	6,770	833,128	May 24 04:17 PM
ODONNELL JEFFREY F	Director	Feb 08	Sale	5.12	42,762	219,100	151,629	Feb 09 09:15 PM
ODONNELL JEFFREY F	Director	Feb 05	Sale	5.00	62,238	311,271	194,391	Feb 09 09:15 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience